Accessibility Menu
Oxford Nanopore Technologies Plc logo

Oxford Nanopore Technologies Plc(LSE) ONT

Market Cap£1.56BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2021)-74%
5 YearN/A
1 Year-14%
1 Month+41%
£1.65
+2.81%
+0.04Today
Oxford Nanopore Technologies Plc last closing stock price
MetricPriceDate
Last closeGBX 160.002026-09-01
Oxford Nanopore Technologies Plc stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-12.57%GBX 183.002026-08-25
1 month+41.09%GBX 113.402026-07-31
3 month+18.96%GBX 134.502026-06-03
Year to date+24.61%GBX 128.402025-12-31
1 year-13.65%GBX 185.302025-09-01
3 year-32.66%GBX 237.602023-09-01
Since inception-73.88%GBX 6.132021-09-30

Oxford Nanopore Technologies Plc Financials at a Glance

Market Cap

£1.56BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

£439.71M

Net Income (TTM)

-£264.74M

EPS (TTM)

-£0.13

P/E Ratio

-12.74

Dividend

£0.00

Beta (Volatility)

0.11 (Low)

Price

£1.65

Volume

172,331

Open

£1.60

Previous Close

£1.60

Daily Range

£1.58 - £1.65

52-Week Range

£0.96 - £1.91

Estimated Earnings Date

Mar 9, 2027

ONT News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Oxford Nanopore Technologies Plc

Oxford Nanopore Technologies plc is a pioneering biotechnology company based in the United Kingdom, specializing in innovative systems for analyzing molecular structures through nanopore-based sensing. The company offers a range of portable and benchtop sequencing devices, enabling real-time analysis of DNA and RNA.

Products and Services
  • MinION: A portable device for DNA and RNA sequencing
  • GridION: A benchtop sequencer for multiple flow cells
  • EPI2ME: A cloud-based platform for real-time data analysis
Growth Outlook
  • Recent quarterly revenue reached £116.7 million, indicating strong market demand
  • TTM gross profit margin stands at 60.2%, showcasing operational efficiency
  • Continued investment in R&D, with £36.9 million allocated in the latest quarter
Financial Highlights
  • Net income for the latest quarter was -£48 million, reflecting ongoing investment in growth
  • Cash and short-term investments totaled £184.8 million, providing liquidity for operations
  • Current ratio of 3.52 indicates strong short-term financial health
Oxford Nanopore Technologies is positioned at the forefront of the biotechnology sector, leveraging its unique technology to meet the growing demand for genomic analysis. The company's diverse product offerings cater to various market needs, from portable sequencing solutions to comprehensive data analysis platforms. Recent financial performance highlights a robust revenue stream and a commitment to research and development, which are critical for sustaining long-term growth. With a solid cash position and a strong current ratio, the company is well-equipped to navigate the challenges of the biotechnology landscape while pursuing innovative advancements.
AI Generated • Aug 21, 2026

Industry

Life Sciences Tools and Services

Sector

Health Care

Employees

1,403

CEO

Gordon Sanghera, PhD

Website

nanoporetech.com

Headquarters

Oxford, OX OX4 4DQ, GB

ONT Financials

Key Financial Metrics (TTM)

Gross Margin

60.18%

Operating Margin

-58.06%

Net Income Margin

-54.66%

Return on Equity

-35.45%

Return on Capital

-30.76%

Return on Assets

-27.82%

Earnings Yield

-7.85%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

£1.56BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

975.36M

Volume

172.33K

Avg. Volume

1.89M

Financials (TTM)

Gross Profit

£259.83M

Operating Income

-£281.31M

EBITDA

-£195.89M

Operating Cash Flow

-£132.11M

Capital Expenditure

-£13.54M

Free Cash Flow

-£145.66M

Cash & ST Invst.

£184.80M

Total Debt

£41.80M

Oxford Nanopore Technologies Plc Performance Analysis

Oxford Nanopore Technologies Plc annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31GBP 198,603,00048.6%
20232023-12-31GBP 169,668,000-14.6%
20242024-12-31GBP 183,191,0008.0%
20252025-12-31GBP 223,900,00022.2%
Oxford Nanopore Technologies Plc sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-3117.9%
Q22025-06-30-46.7%
Q42025-12-31224.1%
Q22026-06-30-31.8%
Oxford Nanopore Technologies Plc annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31GBP -0.11-45.8%
20232023-12-31GBP -0.1967.7%
20242024-12-31GBP -0.16-12.1%
20252025-12-31GBP -0.15-7.2%
Oxford Nanopore Technologies Plc sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-3111.5%
Q22025-06-3051.0%
Q42025-12-31-193.3%
Q22026-06-3055.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

£116.70M

+38.8%

Gross Profit

£72.60M

+46.8%

Gross Margin

62.21%

N/A

Market Cap

£1.56BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

£1.19M

N/A

Employees

1,314

N/A

Net Income

-£48.00M

+35.7%

EBITDA

-£22.00M

+68.7%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

£184.80M

-28.6%

Total Debt

£41.80M

-10.5%

Accounts Receivable

£92.60M

+51.7%

Inventory

£80.40M

-25.6%

Long Term Debt

£36.10M

-13.2%

Short Term Debt

£5.70M

+11.2%

Return on Assets

-27.82%

N/A

Return on Invested Capital

-36.03%

N/A

Free Cash Flow

-£41.50M

+35.9%

Operating Cash Flow

-£39.40M

+28.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
GNS.LGenus plc
£22.92-1.21%
OXB.LOxford Biomedica plc
£4.41-1.34%
AVCT.LAvacta Group Plc
£0.67-1.69%
SCLP.LScancell Holdings plc
£0.10-0.05%

Trending Stocks

Symbol / CompanyPricePrice Chg
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$52.22+0.07%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$39.97+0.04%
TQQQProShares Trust - ProShares UltraPro Qqq
$69.15-0.04%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$105.91-0.06%

Questions About ONT

What is the current price of Oxford Nanopore Technologies Plc?

Oxford Nanopore Technologies Plc is trading at £1.65 per share.

What is the 52-week range for Oxford Nanopore Technologies Plc?

Over the past 52 weeks, Oxford Nanopore Technologies Plc has traded between £0.96 and £1.91.

How much debt does Oxford Nanopore Technologies Plc have?

As of the most recent reporting period, Oxford Nanopore Technologies Plc reported total debt of £41.50M.

How much cash does Oxford Nanopore Technologies Plc have on hand?

Oxford Nanopore Technologies Plc reported £181.10M in cash and cash equivalents in its most recent financial results.

What is Oxford Nanopore Technologies Plc’s dividend yield?

Oxford Nanopore Technologies Plc does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services